Eduardo Gomez-Perez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response.

Cannabinoid CB2 receptor drives trastuzumab resistance and predicts durable anti-HER2 response.

Journal: Oncogene

Published: August 06, 2025

Differential expression of cancer-related genes supports prediction of poor response to first-line treatments in T-ALL pediatric patients with high minimal residual disease.

Differential expression of cancer-related genes supports prediction of poor response to first-line treatments in T-ALL pediatric patients with high minimal residual disease.

Journal: Molecular oncology

Published: May 16, 2025

Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation.

Fatty acid amide hydrolase drives adult mammary gland development by promoting luminal cell differentiation.

Journal: Cell death discovery

Published: November 14, 2023

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia.

Journal: International journal of molecular sciences

Published: May 19, 2023

Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling.

Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling.

Journal: Cancers

Published: March 24, 2023

A Dual Role for FADD in Human Precursor T-Cell Neoplasms.

A Dual Role for FADD in Human Precursor T-Cell Neoplasms.

Journal: International journal of molecular sciences

Published: October 31, 2022

An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer.

An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer.

Journal: Molecular therapy. Nucleic acids

Published: May 31, 2022

Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.

Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.

Journal: Nature communications

Published: April 18, 2022

Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.

Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: February 09, 2019

S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.

S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma.

Journal: Carcinogenesis

Published: December 11, 2018

Appraising the "entourage effect": Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer.

Appraising the "entourage effect": Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer.

Journal: Biochemical pharmacology

Published: May 30, 2018

Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival.

Overexpression of the oncostatin-M receptor in cervical squamous cell carcinoma is associated with epithelial-mesenchymal transition and poor overall survival.

Journal: British journal of cancer

Published: April 22, 2016

Showing 1-12 of 26

Last Updated: 09/26/2026